PCVX Stock: Price, Earnings History and SEC Filings
Vaxcyte, Inc. (PCVX) last traded at $62.03, down 0.93% on the latest session and up 9.0% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-1.97 against an analyst estimate of $-1.47, a miss of 34.0%.
$62.03 -0.93%
1 month+9.02%
52-week high$90.75
52-week low$39.87
Volume1.71M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
PCVX earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $-1.97 | $-1.47 | -34.01% |
| Mar 2026 | May 6, 2026 | $-2.30 | $-1.86 | -23.66% |
| Dec 2025 | Feb 24, 2026 | $-1.80 | $-1.46 | -23.29% |
| Sep 2025 | Nov 4, 2025 | $-1.56 | $-1.27 | -22.83% |
PCVX beat the analyst EPS estimate in 0 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for PCVX
SEC filing data is not available right now. You can search for PCVX on SEC EDGAR.
PCVX news
- Wall Street Analysts See an 87.35% Upside in Vaxcyte (PCVX): Can the Stock Really Move This High?Oct 30, 2026 · finance.yahoo.com
- Vaxcyte Inc.Oct 27, 2026 · marketwatch.com
About Vaxcyte, Inc.
Vaxcyte, Inc. (PCVX) is a US-listed public company on Nasdaq.